One advantage of neoadjuvant therapy in the treatment of breast cancer is the potential to downstage the axilla and reduce the extent of morbid axillary surgery 1,2,3,4,5,6. The nodal response to ...
Evaluation of patients with surgically resected high-risk melanoma receiving adjuvant therapy in routine clinical practice in the United States. *Median (IQR). Millimeters (mm). This is an ASCO ...
Phase III Study of Gemcitabine and Cisplatin With or Without Aprinocarsen, a Protein Kinase C-Alpha Antisense Oligonucleotide, in Patients With Advanced-Stage Non–Small-Cell Lung Cancer Five hundred ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results